Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine Transdermal Patch in Chronic Non-Malignant Pain
NCT01961271Phase 4Completed
- Sponsor
- Mundipharma
- Start
- Jun 2013
- Primary completion
- Jan 2015
- Modality
- Orthosteric Ligands, Inhalation Devices
- Countries
- 3
01
Overview
A Phase 4 trial of v1003 in osteoarthritis (OA), rheumatoid arthritis (RA), low back pain (LBP), arthralgia, myalgia, sponsored by Mundipharma. Started Jun 2013; status: completed.
02
Drugs
v1003
03
Conditions
osteoarthritis (OA)rheumatoid arthritis (RA)low back pain (LBP)arthralgiamyalgia
Beyond the preview
Go deeper on NCT01961271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01961271.